Arch Therapeutics, Inc (OTCQB:ARTH) Employee Directory

Biotechnology ResearchMassachusetts, United States2-10 Employees

Arch Therapeutics, Inc. is a biotechnology company based in Framingham, Massachusetts, focused on developing self-assembling wound care and biosurgical products designed to stop bleeding, control leakage, and manage wounds during surgery, trauma, and interventional care. Its current and development-stage products aim to provide faster and safer care by forming protective barriers at the site of injury or surgical exposure, with regulatory authorization already in place for AC5 Advanced Wound System in the United States and AC5 Topical Hemostat in Europe. The company targets healthcare providers and medical facilities that treat challenging wounds and surgical or interventional scenarios, seeking to improve wound management and hemostasis outcomes. Arch operates in the biotechnology research industry, emphasizing a platform that supports self-assembling barrier technology and related devices, and has pursued commercial activities and partnerships to expand the distribution and adoption of its AC5 product family. A recent development noted is Arch’s participation in a major wound care conference, highlighting the commercialization and presentation of its first commercial product AC5 at industry events.

Sign up for free to view info

Company overview Email format